C4 Therapeutics, Inc.
CCCC
$1.54
$0.042.67%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -16.69% | -3.46% | 18.04% | -1.19% | -4.49% |
Total Receivables | -40.97% | -73.71% | 1,968.20% | 13.52% | 2,475.57% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 20.75% | 70.98% | 9.51% | 77.46% | 2.66% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -16.83% | -4.95% | 22.15% | 0.60% | 0.41% |
|
|||||
Total Current Assets | -16.83% | -4.95% | 22.15% | 0.60% | 0.41% |
Net Property, Plant & Equipment | -11.24% | -10.85% | -10.21% | -9.76% | -9.32% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -30.73% | -1.10% | 30.63% | -7.72% | 30.61% |
Total Assets | -19.79% | -7.13% | 12.93% | 1.62% | 0.59% |
|
|||||
Total Accounts Payable | -58.10% | -8.16% | 17.87% | -59.37% | 57.64% |
Total Accrued Expenses | 0.04% | 12.95% | 1.49% | -41.66% | -28.52% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 10.53% | 10.63% | 10.71% | -64.08% | -24.73% |
Total Finance Division Other Current Liabilities | -37.06% | -0.15% | 114.38% | 152.06% | 130.22% |
Total Other Current Liabilities | -37.06% | -0.15% | 114.38% | 152.06% | 130.22% |
Total Current Liabilities | -25.81% | 5.64% | 43.02% | 12.36% | 39.71% |
|
|||||
Total Current Liabilities | -25.81% | 5.64% | 43.02% | 12.36% | 39.71% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -9.19% | -8.78% | -8.39% | -8.03% | -7.68% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 21.30% | 30.45% | 45.99% | -31.39% | 30.68% |
Total Liabilities | -11.21% | 2.52% | 14.03% | -5.14% | 4.88% |
|
|||||
Common Stock & APIC | 4.87% | 9.68% | 18.40% | 17.08% | 17.22% |
Retained Earnings | -18.55% | -19.93% | -21.37% | -23.12% | -29.27% |
Treasury Stock & Other | 111.32% | 141.73% | 150.33% | 75.20% | 84.62% |
Total Common Equity | -24.45% | -12.24% | 12.33% | 5.71% | -1.60% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -24.45% | -12.24% | 12.33% | 5.71% | -1.60% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -24.45% | -12.24% | 12.33% | 5.71% | -1.60% |
|